New England Research & Management, Inc.

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1596077 CHICAGO, IL

Position in AXSM

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$318,201

New position

Shares Held

1,300

first reported quarter

Ownership

0.002%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#364

of 500 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

New England Research & Management, Inc. holds $4,649,048 across 5 Biotechnology names. AXSM ranks #5 (6.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	3,475	$2,166,801
2	VRTX	Vertex Pharmaceuticals Inc / Ma	2,575	$1,279,079
3	MRNA	Moderna, Inc.	6,850	$479,705
4	INCY	Incyte Corp	3,575	$405,262
5	AXSM	Axsome Therapeutics, Inc. This page	1,300	$318,201

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$318,201	1,300	—	Shares	Sole	2026-07-09
No filing history on record for this holder in this stock.